Kimberly-Clark Corporation

🇺🇸New York Stock Exchange
Back to all articles
Kimberly-Clark Corporation stock analysis KMB overview
Slightly Bullish +25

Aigen Investment Management LP Buys Shares of 10,205 Kimberly-Clark Corporation $KMB - MarketBeat

📈 Aigen Investment Management LP opened a new position buying 10,205 shares of KMB valued at $1.03 million in Q4.

💰 The company reported EPS of $1.97, beating the consensus estimate of $1.93 by $0.04.

📈 Revenue reached $4.16 billion, representing a 2.7% increase year over year.

💸 A quarterly dividend of $1.28 per share was declared with an annualized yield of roughly 5.0%.

🏦 Bank of America lowered its price objective to $120 but maintained a 'buy' rating on the stock.

⚖️ UBS Group raised its target price to $106 while assigning a 'neutral' rating to the shares.

📉 Deutsche Bank Aktiengesellschaft reduced its target price to $109 and set a 'hold' rating.

📉 Zacks Research downgraded KMB from a 'strong-buy' to a 'hold' rating in March.

📊 Institutional investors and hedge funds collectively own 76.29% of the company's outstanding stock.

📉 Insider Katy Chen sold 1,596 shares for $152,162.64 to cover tax withholding obligations.

📉 VP Andrew Scribner sold 4,095 shares for $401,310.00 in a separate transaction.

📉 Total insider sales reached 7,096 shares valued at $689,687 over the last ninety days.

📉 MarketBeat analysts currently list five alternative stocks as better buys than Kimberly-Clark.

📊 The stock trades with a price-to-earnings ratio of 16.06 and a market capitalization of $33.95 billion.

📉 The company has a beta of 0.28, indicating lower volatility compared to the broader market.

Bullish Signals
  • Kimberly-Clark delivered better-than-expected quarterly results with EPS of $1.97 beating analyst estimates of $1.93.
  • Revenue grew by 2.7% year over year to reach $4.16 billion, demonstrating resilient demand for consumer tissue products.
  • The company offers an attractive annualized dividend yield of approximately 5.0%, providing steady income to shareholders.
  • Aigen Investment Management LP initiated a new position, signaling confidence in the stock's fundamentals despite mixed analyst ratings.
  • Other institutional investors like Godfrey Financial Associates and Newbridge Financial Services Group also increased or opened positions in Q4.
  • Bank of America maintains a 'buy' rating with a price objective of $120, suggesting potential upside from current levels.
  • The company reported a strong net margin of 12.80% and a return on equity of 152.79% in the latest quarter.
Risk Factors
  • Zacks Research downgraded Kimberly-Clark from a 'strong-buy' to a 'hold' rating, reflecting concerns about growth or valuation.
  • Deutsche Bank Aktiengesellschaft lowered its price target from $110 to $109 and assigned a 'hold' rating.
  • Insider selling activity was significant in the last ninety days, with executives selling over $689,000 worth of shares for tax reasons.
  • MarketBeat analysts currently recommend five alternative stocks as superior investment choices compared to Kimberly-Clark.
  • The consensus analyst rating is 'Hold', indicating a lack of strong bullish momentum among Wall Street experts.
Full Analysis
Aigen Investment Management LP established a new position in Kimberly-Clark Corporation (KMB) during the fourth quarter, purchasing 10,205 shares valued at approximately $1.03 million. This institutional activity occurred alongside a broader trend of other funds, including Godfrey Financial Associates and Newbridge Financial Services Group, acquiring or increasing stakes in the consumer goods giant. Kimberly-Clark recently reported quarterly earnings that exceeded analyst expectations, with EPS of $1.97 beating estimates of $1.93 and revenue reaching $4.16 billion, a 2.7% year-over-year increase. The company also declared a quarterly dividend of $1.28 per share, payable on July 2nd to shareholders of record on June 5th, resulting in an annualized yield of approximately 5.0%. Despite the positive earnings beat and institutional buying, Wall Street sentiment remains cautious with a consensus 'Hold' rating. Analysts from major firms like Bank of America, UBS, and Deutsche Bank have issued mixed price targets ranging from $106 to $130. Additionally, corporate insiders sold shares totaling over $689,000 in the last ninety days to cover tax obligations, while MarketBeat analysts currently recommend five alternative stocks over KMB.